SESSION 9
Primary and adjuvant systemic therapy of early breast cancer I

Chairs: Daniel F. Hayes (USA), Jens Huober (Germany)

 Neoadjuvant therapy in patients with triple negative and HER2 positive early breast cancer

 Nadia Harbeck, Germany

Neoadjuvant treatment in patients with endocrine responsive/HER2 negative early breast cancer

 Matthew Ellis, USA

 Adjuvant endocrine therapy for premenopausal women: Type and duration

Prudence Francis, Australia

 Adjuvant endocrine therapy in postmenopausal women - tailoring therapy based on tumors and patients

 Harold J. Burstein, USA

  Selecting patients for extended adjuvant endocrine therapy

  Mitch Dowsett, UK

Discussion